Search result for Treatment of Demyelinating Diseases
The United States Patent and Trademark Office gave MetP Pharma US Patent treating Demyelinating, as well as, Neuroinflammatory Diseases
An announcement was made recently by MetP Pharma AG that it has been given a Notice of Allowance from the US Patent and Trademark Office for its patent titled as ‘Treatment of Demyelinating Diseases.’
The patent will be valid until the end of 2039 and will be addressing a me...